Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

CME Group (CME) Q1 Earnings Beat, Revenues Lag Estimates

Published 04/26/2018, 12:15 AM
Updated 07/09/2023, 06:31 AM

CME Group Inc. (NASDAQ:CME) reported first-quarter 2018 adjusted earnings per share of $1.86, beating the Zacks Consensus Estimate of $1.85 by 0.5%. Moreover, the bottom line soared 52.5% year over year.

CME Group Inc. Price, Consensus and EPS Surprise

CME Group Inc. Price, Consensus and EPS Surprise | CME Group Inc. Quote

The year-over-year improvement was mainly owing to higher trading volumes as well as revenues. Also, options business remained sturdy in the quarter.

Notably, the company achieved a record high of average quarterly daily volume in five of its six product lines along with a record high in total options and electronic options.

Net income came in at $1.76 per share, which surged 49.2% year over year. The company’s focus on expense efficiency contributed to this upside.

Performance in Detail

CME Group’s revenues of $1.11 billion improved 19.3% year over year. However, the top line missed the Zacks Consensus Estimate of $1.12 billion by 1.2%. Increase in revenues can be attributable to higher clearing and transaction fees (up 22.9% year over year) as well as access and communication fees (up nearly 7% from the year-ago quarter). Also, broad-based strength across all of the company’s asset classes aided this improvement.

Total expenses increased 12.1% year over year to $368.1 million during the reported quarter, attributable to higher compensation and benefits, technology support services, professional fees and outside services, licensing and other fee agreements and other.

Operating income improved 23.3% to $740.9 million from the prior-year quarter.

Average daily volume (ADV) increased nearly 30% year over year to an all-time high of 22.2 million contracts, backed by higher volumes across all the six product lines. Average rate per contract rose in only two of the six product lines.

Financial Update

As of Mar 31, 2018, CME Group had $875 million of cash and marketable securities, which plunged 56.1% from the tally at 2017 end. As of Mar 31, 2018, long-term debt of $2.2 billion remained flat with the level at year-end 2017.

As of Mar 31, 2018, the company had total assets worth $69.9 billion, down 7.7% from $75.8 billion at year-end 2017.

Dividend Update

During the reported quarter, the company paid dividends worth $1.4 billion comprising the annual variable dividend of $1.2 billion and the regular first-quarter dividend of $238 million.

Zacks Rank

CME Group holds a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Performance of Other Companies in Securities Exchange Industry

The bottom line of Nasdaq, Inc. (NASDAQ:NDAQ) and MarketAxess Holdings Inc. (NASDAQ:MKTX) beat the respective Zacks Consensus Estimate in the quarter under review.

Intercontinental Exchange, Inc. (NYSE:ICE) will report first-quarter results on May 5 before the market opens. The Zacks Consensus Estimate for earnings is pegged at 88 cents, up 18.9% year over year.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple (NASDAQ:AAPL) sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>



Intercontinental Exchange Inc. (ICE): Free Stock Analysis Report

CME Group Inc. (CME): Free Stock Analysis Report

Nasdaq, Inc. (NDAQ): Free Stock Analysis Report

MarketAxess Holdings Inc. (MKTX): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.